Blood Res.  2013 Dec;48(4):297-298. 10.5045/br.2013.48.4.297.

Late but effective long-term response to splenectomy in the treatment of immune thrombocytopenia

• Scaramucci L
• Giovannini M
• Tendas A
• Niscola P
• de Fabritiis P

• KMID: 2172881
• DOI: http://doi.org/10.5045/br.2013.48.4.297

Abstract

No abstract available.

MeSH Terms

Splenectomy*
Thrombocytopenia*

Reference

1. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010; 115:168–186. PMID: 19846889.

2. Ojima H, Kato T, Araki K, et al. Factors predicting long-term responses to splenectomy in patients with idiopathic thrombocytopenic purpura. World J Surg. 2006; 30:553–559. PMID: 16568220.

3. Wang M, Zhang M, Zhou J, et al. Predictive factors associated with long-term effects of laparoscopic splenectomy for chronic immune thrombocytopenia. Int J Hematol. 2013; 97:610–616. PMID: 23591716.

4. Boyle S, White RH, Brunson A, Wun T. Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia. Blood. 2013; 121:4782–4790. PMID: 23637127.

5. Stasi R, Newland A, Thornton P, Pabinger I. Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate. Ann Hematol. 2010; 89:1185–1195. PMID: 20842501.